The Impact of Mass Oral Cholera Vaccination in South Kivu, Democratic Republic of the Congo
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 221688/Z/20/Z
Grant search
Key facts
Disease
CholeraStart & end year
20202026Known Financial Commitments (USD)
$1,910,354.19Funder
Wellcome TrustPrincipal Investigator
Dr. Andrew S AzmanResearch Location
CongoLead Research Institution
Johns Hopkins UniversityResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Characterisation of vaccine-induced immunity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Here we aim to study the impact of massive cholera vaccination in Uvira, DR Congo through a multifaceted approach aimed at estimating changes in clinical disease incidence, infection rates, and the type and frequency of occurrence of toxigenic V. cholerae in the environment. Successful completion of this project will provide critical insights into the impact that mass OCV campaigns can have on human health while at the same time providing a new understanding of the epidemiology of cholera in this hyper-endemic setting. Our specific objectives are: Objective 1: To enhance the cholera surveillance system in Uvira, South Kivu, DR Congo in order to estimate the impact of mass vaccination on lab-confirmed cholera incidence and mortality. Objective 2: To conduct serial cross-sectional serosurveys before and after vaccination to estimate the impact of vaccination on seroincidence of V. cholerae infection in Uvira. Objective 3: To use phenotypic and molecular methods to describe the changes in the V. cholerae population after vaccination in both human and environmental samples in Uvira.